Clearmind Announces Initiation Of CMND-100 Manufacturing Program To Address Its Upcoming Clinical Trial
Clearmind Medicine Inc. (NASDAQ:CMND), (CSE:CMND), (FSE: CWY) ("Clearmind" or the "Company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve